RNA sequencing: Platform selection, experimental design, and data interpretation

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Detailed characterization of cellular RNA facilitates the design of nucleic acid therapeutics and interpretation of experimental data. Since the first reports of next generation sequencing (NGS) technology-based RNA sequencing (RNA-seq) (Nagalakshmi et al., 2008; Wilhelm, et al., 2008), rapid advances in experimental protocol development and data acquisition and analysis have brought comprehensive sequencing of cellular RNA within reach of most laboratories (Martin and Wang, 2011; Ozsolak and Milos, 2011). While RNA-seq is becoming widely used for laboratory research and clinical studies, the field is still new and strategies for successfully applying RNA-seq to a given experimental problem are often obscure. The goal of this perspective is to introduce some of the choices confronted during RNA sequencing and analysis.

Original languageEnglish (US)
Pages (from-to)271-274
Number of pages4
JournalNucleic Acid Therapeutics
Volume22
Issue number4
DOIs
StatePublished - Aug 1 2012

Fingerprint

RNA Sequence Analysis
Design of experiments
Research Design
RNA
Clinical laboratories
Nucleic Acids
Research laboratories
Data acquisition
Technology
Research

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Biochemistry
  • Drug Discovery

Cite this

RNA sequencing : Platform selection, experimental design, and data interpretation. / Chu, Yongjun; Corey, David R.

In: Nucleic Acid Therapeutics, Vol. 22, No. 4, 01.08.2012, p. 271-274.

Research output: Contribution to journalArticle

@article{d75c53721e204ad0b1b7e6b13c2ed1f5,
title = "RNA sequencing: Platform selection, experimental design, and data interpretation",
abstract = "Detailed characterization of cellular RNA facilitates the design of nucleic acid therapeutics and interpretation of experimental data. Since the first reports of next generation sequencing (NGS) technology-based RNA sequencing (RNA-seq) (Nagalakshmi et al., 2008; Wilhelm, et al., 2008), rapid advances in experimental protocol development and data acquisition and analysis have brought comprehensive sequencing of cellular RNA within reach of most laboratories (Martin and Wang, 2011; Ozsolak and Milos, 2011). While RNA-seq is becoming widely used for laboratory research and clinical studies, the field is still new and strategies for successfully applying RNA-seq to a given experimental problem are often obscure. The goal of this perspective is to introduce some of the choices confronted during RNA sequencing and analysis.",
author = "Yongjun Chu and Corey, {David R.}",
year = "2012",
month = "8",
day = "1",
doi = "10.1089/nat.2012.0367",
language = "English (US)",
volume = "22",
pages = "271--274",
journal = "Nucleic Acid Therapeutics",
issn = "2159-3337",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - RNA sequencing

T2 - Platform selection, experimental design, and data interpretation

AU - Chu, Yongjun

AU - Corey, David R.

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Detailed characterization of cellular RNA facilitates the design of nucleic acid therapeutics and interpretation of experimental data. Since the first reports of next generation sequencing (NGS) technology-based RNA sequencing (RNA-seq) (Nagalakshmi et al., 2008; Wilhelm, et al., 2008), rapid advances in experimental protocol development and data acquisition and analysis have brought comprehensive sequencing of cellular RNA within reach of most laboratories (Martin and Wang, 2011; Ozsolak and Milos, 2011). While RNA-seq is becoming widely used for laboratory research and clinical studies, the field is still new and strategies for successfully applying RNA-seq to a given experimental problem are often obscure. The goal of this perspective is to introduce some of the choices confronted during RNA sequencing and analysis.

AB - Detailed characterization of cellular RNA facilitates the design of nucleic acid therapeutics and interpretation of experimental data. Since the first reports of next generation sequencing (NGS) technology-based RNA sequencing (RNA-seq) (Nagalakshmi et al., 2008; Wilhelm, et al., 2008), rapid advances in experimental protocol development and data acquisition and analysis have brought comprehensive sequencing of cellular RNA within reach of most laboratories (Martin and Wang, 2011; Ozsolak and Milos, 2011). While RNA-seq is becoming widely used for laboratory research and clinical studies, the field is still new and strategies for successfully applying RNA-seq to a given experimental problem are often obscure. The goal of this perspective is to introduce some of the choices confronted during RNA sequencing and analysis.

UR - http://www.scopus.com/inward/record.url?scp=84865420834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865420834&partnerID=8YFLogxK

U2 - 10.1089/nat.2012.0367

DO - 10.1089/nat.2012.0367

M3 - Article

C2 - 22830413

AN - SCOPUS:84865420834

VL - 22

SP - 271

EP - 274

JO - Nucleic Acid Therapeutics

JF - Nucleic Acid Therapeutics

SN - 2159-3337

IS - 4

ER -